Choosing a drug to treat motion sickness.

IF 0.8 4区医学 Q3 MEDICINE, GENERAL & INTERNAL

Jaapa-Journal of the American Academy of Physician Assistants Pub Date : 2025-03-01 Epub Date: 2025-02-25 DOI:10.1097/01.JAA.0000000000000097

Gayle B Bodner, Courtney J Perry

引用次数: 0

Abstract

Abstract: Patients who suffer from motion sickness despite avoiding triggers and using behavioral modifications may benefit from individualized recommendations for pharmacologic therapy. Patients with refractory motion sickness can benefit from prophylactic drug therapy using first-generation antihistamines or scopolamine.

查看原文本刊更多论文

选择治疗晕车的药物

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Jaapa-Journal of the American Academy of Physician Assistants MEDICINE, GENERAL & INTERNAL-

CiteScore

1.20

自引率

9.10%

发文量

310

期刊介绍： JAAPA is the peer-reviewed clinical journal of the American Academy of Physician Assistants (AAPA). Published for more than 25 years, its mission is to support the ongoing education and advancement of physician assistants (PAs) by publishing current information and research on clinical, health policy, and professional issues. Published monthly, JAAPA''s award-winning editorial includes: -Clinical review articles (with AAPA-approved Category I CME in each issue)- Case reports- Clinical departments- Original health services research- Articles on issues of professional interest to PAs